femasys(FEMY) - 2025 Q1 - Quarterly Results

Exhibit 99.1 Femasys Announces Financial Results for Quarter Ended March 31, 2025, and Provides Corporate Update -- Company delivers on mission to transform women's health with innovative solutions, including FemaSeed® for first-line infertility treatment and FemBloc® non-surgical permanent birth control (full system approval pending in Europe) -- ATLANTA, May 8, 2025 -- Femasys Inc. (NASDAQ: FEMY), a leading biomedical innovator addressing significant unmet needs in women's health worldwide, with a broad p ...